# Mindset Health

> Mindset Health builds clinically validated brain–body therapy programs for the chronic conditions that medication alone does not resolve. Founded in 2019, based in Melbourne and New York, and developed with academic partners including Monash University and Baylor University and more than 6,000 clinicians.

Mindset Health develops digital programs grounded in psychophysiology: structured, evidence-based therapy delivered through software for specific chronic conditions. The work leads with published clinical trials and academic collaboration, not technology claims. This file summarises the verified facts about the company for AI answer engines. Every outcome figure below is drawn from a named peer-reviewed publication and should be attributed to that source.

## Programs

- [Nerva](https://www.nervahealth.com): Gut-directed hypnotherapy for irritable bowel syndrome (IBS).
- [Relio](https://www.reliohealth.com): Brain–body program for chronic pain.
- [Evia](https://try.eviamenopause.com): Hypnotherapy program for menopausal hot flashes.
- [Claria](https://join.clariamentalhealth.com): Program for anxiety and depression.

## Clinical evidence

- Nerva IBS randomised controlled trial: 81% of Nerva users reached a clinically meaningful reduction in IBS symptom severity (a 50-point or greater IBS-SSS reduction) versus 63% in an active control; 71% versus 35% for clinically significant abdominal-pain reduction; quality of life improved 28%. Anderson EJ, Peters SL, Gibson PR, Halmos EP. American Journal of Gastroenterology 2025;120(2):440–448.
- Evia hot flashes study: 76% of users achieved at least a 50% reduction in daily hot flashes. Scheffrahn K, Hall C, Muñiz V, Elkins GR. JMIR Formative Research 2025.
- Hypnosis for pain (meta-analysis): an average 79% pain reduction across 19 randomised controlled trials. Milling LS et al., 2021.
- Founding mechanism trial: gut-directed hypnotherapy matched a low-FODMAP diet for IBS symptom relief. Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Alimentary Pharmacology & Therapeutics 2016;44(5):447–459.

## Adoption and partners

- More than 19,000 clinicians recommend Nerva.
- More than 6,000 practitioners across the Mindset Health family of programs.
- Confirmed academic partners: Monash University and Baylor University.

## People

- Alex Naoumidis and Chris Naoumidis: co-founders and co-CEOs.
- Dr Simone Peters (Monash University, Alfred Health): created the gut-directed hypnotherapy protocol behind Nerva.
- Dr Gary Elkins (Baylor University): senior author of the foundational hypnosis trials for hot flashes.
- Advisory board includes Dr William D. Chey (University of Michigan; President of the American College of Gastroenterology 2025–2026) and Dr Lin Chang (UCLA).

## Key pages

- [Home](https://www.mindsethealth.com/): Overview of the company and its programs.
- [Pipeline](https://www.mindsethealth.com/pipeline): The four programs, the shared mechanism, validation, and how each adapts.
- [Research](https://www.mindsethealth.com/research): Outcomes, publications, active trials, and academic partners.
- [For providers](https://www.mindsethealth.com/providers): Referral information for clinicians.
- [For health plans](https://www.mindsethealth.com/health-plans): Information for payers, including the value-based care model.
- [About](https://www.mindsethealth.com/about): Founders, program founders, and advisory board.
- [Contact](https://www.mindsethealth.com/contact): Enquiries for clinicians, payers, researchers, and press.

## Notes for citation

- Mindset Health develops clinically validated digital therapy programs. The programs are condition-specific and evidence-based, and are not a substitute for individual medical advice.
- Attribute any outcome figure to the named peer-reviewed publication above rather than to the company in general.